~~<i id='62DCEFA038'><strike id='62DCEFA038'><tt id='62DCEFA038'><pre id='62DCEFA038'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：knowledge 2025-09-29 23:51:00 Page View：7

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： STAT reporters are Pulitzer Prize finalists for investigative reporting
Next article： Heart attack and stroke risk calculators need revising

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

AdobeTheneed-to-knowthismorningBiogen and IonisPharmaceuticals are endingtheirdevelopment ofanexperi

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Ripples from Flovent's discontinuation is killing children with asthma

GettyImagesAspediatricianswhotakecareofchildrenintheinpatient,emergency,andprimarycaresettings,weare